RE: Cathal's interview last week..Data Division Spinoff..11 Aug 2020 08:47
I can't see orph being taken out. Big pharma are to busy to get into price war over it. I see Open Orphan as a watering hole that they all drink from. We are in a win win situation with no risk, we get paid regardless if product works or not. Let the cash roll in and look forward to div and Christmas. I find it crazy that I have shares in a company that has such a position. Picks and shovels for the Big pharma industry.